Results
1 -
10 of
29Development of potent non-peptide GPIIb/IIIa antagonists with tri-substituted ??-amino acid derivatives as a new conformational restriction unit, Peptide Science ? Present and Future Oral Agents, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Oral Platelet Glycoprotein IIb/IIIa Blockade, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial, Journal of Thrombosis and Thrombolysis Oral glycoprotein IIb/IIIa antagonists in coronary artery disease, Current Cardiology Reports Development and Use of Platelet Glycoprotein Antagonists in Heart Disease, Cardiac Drug Development Guide Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease, Trials Highlights of Latest Advances in Antithrombotics, Anticoagulants, Antiplatelets, and Thrombolytics